Out of 60 participants with biopsy confirmed prostate adenocarcinoma, Ga-68 PSMA PET/CT detected lesions in all 60, whereas 55 were detected by mpMRI. This evidence concerns the gene FOLH1 and prostate adenocarcinoma.